These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 239050)

  • 1. Cross-reactive antigens and immunity to diseases caused by encapsulated bacteria.
    Robbins JB; Schneerson R; Glode MP; Vann W; Schiffer MS; Liu TY; Parke JC; Huntley C
    J Allergy Clin Immunol; 1975 Aug; 56(2):141-51. PubMed ID: 239050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteric bacteria cross-reactive with Neisseria meningitidis groups A and C and Diplococcus pneumoniae types I and 3.
    Robbins JB; Myerowitz L; Whisnant JK; Argaman M; Schneerson R; Handzel ZT; Gotschlich EC
    Infect Immun; 1972 Nov; 6(5):651-6. PubMed ID: 4118016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary-tract escherichia coli with cross-reactive antigens to encapsulated pyogenic bacteria.
    Myerowitz RL; Schneerson R; Robbins JB; Turck M
    Lancet; 1972 Aug; 2(7771):250-3. PubMed ID: 4114507
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune responses to polysaccharides: lessons from humans and mice.
    González-Fernández A; Faro J; Fernández C
    Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polysaccharides of the genus Bacillus cross-reactive with the capsular polysaccharides of Diplococcus pneumoniae type 3, Haemophilus influenzae type b, and Neisseria meningitidis group A.
    Myerowitz RL; Gordon RE; Robbins JB
    Infect Immun; 1973 Dec; 8(6):896-900. PubMed ID: 4150383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: Fecal flora and resistance to invasive bacteria.
    Anderson P
    N Engl J Med; 1975 May; 292(21):1124-5. PubMed ID: 1093021
    [No Abstract]   [Full Text] [Related]  

  • 7. Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis.
    Siber GR; Ambrosino DM; McIver J; Ervin TJ; Schiffman G; Sallan S; Grady GF
    Infect Immun; 1984 Jul; 45(1):248-54. PubMed ID: 6429048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial polysaccharides as vaccines--immunity and chemical characterization.
    Lee CJ; Lee LH; Lu CS; Wu A
    Adv Exp Med Biol; 2001; 491():453-71. PubMed ID: 14533815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capsular polysaccharides as human vaccines.
    Jennings HJ
    Adv Carbohydr Chem Biochem; 1983; 41():155-208. PubMed ID: 6195893
    [No Abstract]   [Full Text] [Related]  

  • 10. Present status of polysaccharide vaccines in the prevention of meningococcal disease.
    Gold R; Lepow ML
    Adv Pediatr; 1976; 23():71-93. PubMed ID: 12651
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.
    Blanchard-Rohner G; Pollard AJ
    Expert Rev Vaccines; 2011 May; 10(5):673-84. PubMed ID: 21604987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of serum Haemophilus influenzae type B capsular antibodies in adult volunteers fed cross-reacting Escherichia coli 075:K100:H5.
    Schneerson R; Robbins JB
    N Engl J Med; 1975 May; 292(21):1093-6. PubMed ID: 48191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group-specific polysaccharide antigen and humoral antibody response in disease due to Neisseria meningitidis.
    Hoffman TA; Edwards EA
    J Infect Dis; 1972 Dec; 126(6):636-44. PubMed ID: 4123779
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.
    Siber GR; Thompson C; Reid GR; Almeido-Hill J; Zacher B; Wolff M; Santosham M
    J Infect Dis; 1992 Jun; 165 Suppl 1():S129-33. PubMed ID: 1588146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The contribution of latex tests for the diagnosis of bacterial infections in Abidjan].
    Akoua-Koffi G; Faye-Kette-Achi H; Sylla-Koko F; Kacou-Ndouba A; Acho YB; Avoaka-Cisse L; Bouzid SA; Kouassi AA; Dosso M
    Bull Soc Pathol Exot; 1994; 87(2):77-80. PubMed ID: 8061531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid bacterial antigen detection is not clinically useful.
    Perkins MD; Mirrett S; Reller LB
    J Clin Microbiol; 1995 Jun; 33(6):1486-91. PubMed ID: 7650172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum antibodies specific to CD outer membrane protein of Moraxella catarrhalis, P6 outer membrane protein of non-typeable Haemophilus influenzae and capsular polysaccharides of Streptococcus pneumoniae in children with otitis media with effusion.
    Harabuchi Y; Murakata H; Goh M; Kodama H; Kataura A; Faden H; Murphy TF
    Acta Otolaryngol; 1998 Nov; 118(6):826-32. PubMed ID: 9870628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A girl with recurrent infections, low IgM and an abnormal chromosome number 1.
    Ostergaard PA
    Acta Paediatr Scand; 1973 Mar; 62(2):211-5. PubMed ID: 4570826
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of Pneumococcal Conjugate Vaccine on the Natural Antibodies and Antibody Responses Against Protein Antigens From Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Children With Community-acquired Pneumonia.
    Andrade DC; Borges IC; Adrian PV; Meinke A; Barral A; Ruuskanen O; Käyhty H; Nascimento-Carvalho CM
    Pediatr Infect Dis J; 2016 Jun; 35(6):683-9. PubMed ID: 26954601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of bacterial diseases by detection of serum antigens by counterimmunoelectrophoresis, sensitivity, and specificity of detecting Pseudomonas and pneumococcal antigens.
    Bartram CE; Crowder JG; Beeler B; White A
    J Lab Clin Med; 1974 Apr; 83(4):591-8. PubMed ID: 4150397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.